ETHZilla Corp — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-02-26

Reporting Person: Pamir Ozan (Interim CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-26	Stock Option (Right to Buy)	$4.43	A	180000	Acquired	2031-02-26	Common Stock (180000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	72608	Direct

Footnotes

F1: The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as Interim Chief Financial Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.

F2: The options vest at the rate of (a) 1/5th of such options on the grant date; and (b) 4/5th of such options vesting ratably on a monthly basis over the following 36 months on the last day of each calendar month, subject to the Reporting Person's continued service to the Company on such vesting dates.